Cambridge Cognition (COG) Sets New 12-Month Low at $66.00

Shares of Cambridge Cognition Holdings PLC (LON:COG) hit a new 52-week low during mid-day trading on Monday . The company traded as low as GBX 66 ($0.86) and last traded at GBX 69 ($0.90), with a volume of 18665 shares trading hands. The stock had previously closed at GBX 70.50 ($0.92).

Separately, FinnCap restated a “corporate” rating on shares of Cambridge Cognition in a report on Thursday, January 31st.

The company has a market cap of $16.61 million and a PE ratio of -9.86.

ILLEGAL ACTIVITY WARNING: “Cambridge Cognition (COG) Sets New 12-Month Low at $66.00” was posted by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are viewing this news story on another domain, it was copied illegally and reposted in violation of US and international copyright legislation. The original version of this news story can be viewed at

About Cambridge Cognition (LON:COG)

Cambridge Cognition Holdings Plc, a neuroscience technology company, develops digital health products. The company offers CANTAB Recruit, an online patient recruitment platform for pharmaceutical and biotechnology companies to identify qualified clinical trial participants in high-need indications, such as Alzheimer's disease; CANTAB Connect that provides digital cognitive assessment solutions for pharmaceutical clinical trials in various therapeutic areas from phases I–IV or a cognitive testing software that enhances the chances of success and minimizing the risk of failure in neuroscience research; and Cognition Kit, a digital health platform, which delivers wearable and smartphone apps to provide engaging digital health solutions for the enhancement of patient engagement, demonstration of treatment efficacy, and understanding of a disease and a patient's response to medication.

Read More: How to execute a trade ex-dividend strategy?

Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with's FREE daily email newsletter.